Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Infectious Disorders - Drug Targets is Scopus-indexed (Q3, CiteScore 2.9). It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1871-5265Verify ISSN ↗2212-3989Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Microbiology (medical) | 92 / 147 | 37th | Q3 |
| Pharmacology | 213 / 328 | 35th | Q3 |
| Molecular Medicine | 142 / 179 | 20th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q3, CiteScore 2.9.
Infectious Disorders - Drug Targets is Q3 in Microbiology (medical) (rank 92 of 147), Q3 in Pharmacology (rank 213 of 328) and Q4 in Molecular Medicine (rank 142 of 179), by CiteScore 2025.
Infectious Disorders - Drug Targets is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.9, quartile Q3, 37th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.308, quartile Q3, with an H-index of 64.
Infectious Disorders - Drug Targets is published by Bentham Science Publishers. Its print ISSN is 1871-5265 and its online ISSN is 2212-3989.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Infectious Disorders - Drug Targets has an h-index of 58 and a 2-year mean of 1.27 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q3. On 2-year citations it ranks #98 of 144 Scopus journals in Microbiology (medical).
Infectious Disorders - Drug Targets published 52 papers in 2025; its busiest recent year was 2020 with 161. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from India (49%), Iran (21.7%) and United Arab Emirates (3.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.